AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 190 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $745,842 | -21.7% | 95,990 | -2.5% | 0.46% | -17.1% |
| Q2 2023 | $953,064 | -12.8% | 98,457 | -1.2% | 0.55% | -19.6% |
| Q1 2023 | $1,092,679 | +170.1% | 99,697 | +6.4% | 0.68% | +155.8% |
| Q4 2022 | $404,603 | -58.7% | 93,658 | -28.1% | 0.27% | -61.0% |
| Q3 2022 | $980,000 | -26.8% | 130,310 | -2.1% | 0.68% | -23.5% |
| Q2 2022 | $1,338,000 | -18.8% | 133,155 | +0.0% | 0.90% | -0.1% |
| Q1 2022 | $1,648,000 | -45.3% | 133,117 | +1.0% | 0.90% | -39.9% |
| Q4 2021 | $3,013,000 | -18.9% | 131,760 | -21.5% | 1.49% | -22.6% |
| Q3 2021 | $3,715,000 | +70.3% | 167,889 | -0.3% | 1.92% | +74.8% |
| Q2 2021 | $2,181,000 | -1.4% | 168,318 | -1.2% | 1.10% | -5.8% |
| Q1 2021 | $2,212,000 | +11.8% | 170,316 | +19.0% | 1.17% | +0.9% |
| Q4 2020 | $1,979,000 | -7.7% | 143,078 | -1.7% | 1.16% | -24.4% |
| Q3 2020 | $2,145,000 | -9.5% | 145,600 | -0.1% | 1.53% | -16.9% |
| Q2 2020 | $2,369,000 | +11.3% | 145,780 | -0.6% | 1.85% | -13.4% |
| Q1 2020 | $2,129,000 | -31.3% | 146,697 | -4.1% | 2.13% | -0.5% |
| Q4 2019 | $3,100,000 | +256.3% | 152,989 | -6.1% | 2.14% | +228.4% |
| Q3 2019 | $870,000 | -19.1% | 162,960 | -0.3% | 0.65% | -22.5% |
| Q2 2019 | $1,076,000 | -8.3% | 163,460 | -9.5% | 0.84% | -11.8% |
| Q1 2019 | $1,174,000 | -25.7% | 180,647 | -22.0% | 0.95% | -34.8% |
| Q4 2018 | $1,580,000 | +11.8% | 231,681 | +8.8% | 1.46% | +48.1% |
| Q3 2018 | $1,413,000 | +14.8% | 212,865 | -2.6% | 0.99% | +13.1% |
| Q2 2018 | $1,231,000 | +28.0% | 218,568 | +18.0% | 0.87% | +24.2% |
| Q1 2018 | $962,000 | +14.3% | 185,289 | -0.3% | 0.70% | +16.8% |
| Q4 2017 | $842,000 | -30.1% | 185,865 | -3.3% | 0.60% | -28.9% |
| Q3 2017 | $1,205,000 | +23.6% | 192,177 | +20.8% | 0.85% | +20.0% |
| Q2 2017 | $975,000 | +29.3% | 159,092 | +54.9% | 0.71% | +25.2% |
| Q1 2017 | $754,000 | – | 102,730 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 503,248 | $6,535,000 | 10.30% |
| Prosight Management, LP | 360,834 | $4,685,000 | 3.84% |
| Healthcare Value Capital, LLC | 100,000 | $1,299,000 | 2.89% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,748,208 | $22,700,000 | 2.32% |
| DG Capital Management, LLC | 591,154 | $7,676,000 | 1.83% |
| NEA Management Company, LLC | 5,172,683 | $67,193,000 | 1.51% |
| Altium Capital Management LP | 408,908 | $5,310,000 | 1.47% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 170,316 | $2,212,000 | 1.17% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 298,500 | $3,875,000 | 1.02% |
| KNOTT DAVID M | 154,840 | $2,011,000 | 0.86% |